The European Union’s antitrust regulators have blocked a planned merger between genetic sequencing company Illumina, Inc. and cancer detection test manufacturer Grail, Inc.
EU Rejects Illumina Acquisition Of Grail
The European Union’s antitrust commission blocked the re-acquisition of Grail by Illumina days after an FTC administrative law judge ruled in favor of the merger in the US.
